Clinical Trial Update: A Prospective, Open, Non-randomized Phase I/II Study of Therapeutic Angiogenesis in Diabetic Patients With Critic Ischemia of Lower Limbs While Administering Positive CD133 Mobilized With G-CSF [Phase 1, Phase 2]

View source ↗

Summary

An open-label Phase I/II trial evaluating CD133+ cells mobilized with G-CSF for therapeutic angiogenesis in diabetic patients with critical limb ischemia; the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia
• Diabetes Mellitus

Drugs mentioned

• CD133+ cells mobilized by G-CSF

Snippet

Sponsor: PETHEMA Foundation | Conditions: Diabetic Patients With Critic Ischemia in Lower Limbs Who Are Administered With CD133+ Cells Mobilized by G-CSF | Phase 1, Phase 2 | Status: TERMINATED